Aurinia Pharmaceuticals Inc. (AUPH) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$12,764
Total Return
27.64%
CAGR
5.00%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +2.28% |
| Median | +0.57% |
| Best | +127.98% |
| Worst | -46.11% |
| % of Windows Positive | 51.7% |
1-Year (252 Trading Days)
| Average | +6.94% |
| Median | -2.83% |
| Best | +125.30% |
| Worst | -84.21% |
| % of Windows Positive | 45.6% |
3-Year (756 Trading Days)
| Average | +3.69% |
| Median | -30.89% |
| Best | +273.48% |
| Worst | -77.90% |
| % of Windows Positive | 35.4% |
Risk Metrics
| Maximum Drawdown | -87.58% |
| Average Drawdown | -62.78% |
| Drawdown Duration | 1116 Trading Days (Unrecovered) |
| Sortino Ratio | 0.62 |
| Calmar Ratio | 0.06 |
| CVaR (5%) | -9.35% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +0.75% (+2.67% ann.) | +$75.24 | $0.00 | $0.00 | $0.00 |
| 2025 | +77.62% | +$7761.69 | $0.00 | $0.00 | $0.00 |
| 2024 | -0.11% | $11.12 | $0.00 | $0.00 | $0.00 |
| 2023 | +108.10% | +$10810.19 | $0.00 | $0.00 | $0.00 |
| 2022 | -81.11% | $8111.06 | $0.00 | $0.00 | $0.00 |
| 2021 | +65.37% | +$6536.51 | $0.00 | $0.00 | $0.00 |
| 2020 | -31.74% | $3173.74 | $0.00 | $0.00 | $0.00 |
| 2019 | +197.07% | +$19706.74 | $0.00 | $0.00 | $0.00 |
| 2018 | +50.55% | +$5055.19 | $0.00 | $0.00 | $0.00 |
| 2017 | +115.71% | +$11571.43 | $0.00 | $0.00 | $0.00 |
| 2016 | -14.98% | $1497.98 | $0.00 | $0.00 | $0.00 |
| 2015 | -32.14% | $3214.29 | $0.00 | $0.00 | $0.00 |
| 2014 partial | -9.00% (-25.13% ann.) | $900.00 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | September 3, 2014 – February 19, 2020 | +400.75% | +34.30% | +$40075.00 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -38.85% | -99.64% | $3885.07 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +1.92% | +3.11% | +$192.45 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +32.61% | +30.70% | +$3261.03 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -73.30% | -75.39% | $7330.15 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +34.21% | +17.20% | +$3421.05 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | +126.98% | +68.62% | +$12697.74 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.